SCHEMBL4405345

SCHEMBL4405345

CCOc1cc(OC)cc(N)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.42
KDM4E B2RXH2 2/20 0.42
GAA P10253 1/20 0.42
ALDH1A1 P00352 4/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
HSD17B10 Q99714 2/20 0.42
POLB P06746 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CALM1 P0DP23 2/20 0.41
CYP3A4 P08684 1/20 0.39
THRB P10828 1/20 0.39
PDE4A P27815 2/20 0.39
PDE4B Q07343 2/20 0.39
PDE4C Q08493 2/20 0.39
PDE4D Q08499 2/20 0.39
TAAR1 Q96RJ0 1/20 0.38
ABL1 P00519 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4409340 0.89 MAPT (0.44) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL4405978 0.86 MAPT (0.42) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL29513975 0.83 ALDH1A1 (0.50) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL4406554 0.83 ALDH1A1 (0.50) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL18670662 0.78 MAOB (0.50) MAPTGAAMAPK1L3MBTL1ABCB1
SCHEMBL4401870 0.76 ALDH1A1 (0.43) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL4403734 0.76 PDE4A (0.41) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL4398320 0.76 ABL1 (0.39) KDM4ECALM1PDE4APDE4BPDE4C
SCHEMBL4406758 0.74 KDM4E (0.49) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL7294552 0.74 ALDH1A1 (0.66) MAPTKDM4EGAAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1549651-B1 PYRIMIDOPYRIMIDONES AS KINASE INHIBITORS WARNER LAMBERT CO (US) 2009-12-23 EP disclosed
US-7196090-B2 Kinase inhibitors WARNER-LAMBERT COMPANY (US) 2007-03-27 US disclosed
EP-1549651-A1 KINASE INHIBITORS Warner-Lambert Company LLC (US) 2005-07-06 EP disclosed
WO-2004011465-A1 KINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2004-02-05 WO disclosed
US-20040019210-A1 Kinase inhibitors CHIVIKAS CONNOLLY CLEO J (US) 2004-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019210-A1 Kinase inhibitors CDK2, CDK1, CDK4 MAPT 3541/4885KDM4E 954/4885GAA 1727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.